Latest Organofluorides Stories

VAN BUREN TOWNSHIP, Mich., Sept. 5, 2012 /PRNewswire/ -- A wide range of vehicles going into production this year are the first to feature an innovative "zero leak" air conditioning fitting from Visteon Corporation (NYSE: VC). (Logo: http://photos.prnewswire.com/prnh/20001201/DEF008LOGO ) Visteon developed the patented metal seal fitting to eliminate refrigerant leakage stemming from air conditioning connections in vehicles. The fitting is designed to be very robust, resisting...

GRAND RAPIDS, Mich., Sept. 4, 2012 /PRNewswire/ -- In an effort to help families be heart healthy, this week Midwest retailer Meijer began offering the generic substitute for Lipitor®* (atorvastatin calcium) for free in all 199 Meijer pharmacies. The addition expands the retailer's free medication program, and makes Meijer the first retailer in the Midwest to offer this generic cholesterol lowering medication - up to 30 tablets per fill in 10, 20, 40 and 80 mg strengths - free to...

WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif., Aug. 30, 2012 /PRNewswire/ -- Bayer HealthCare and Onyx Pharmaceuticals (NASDAQ: ONXX) today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients whose disease has progressed despite prior treatment. Regorafenib is a...

The findings were presented by Dr Jolanta Siller-Matula from Medical University of Vienna Standard antiplatelet treatment in patients undergoing percutaneous coronary intervention (PCI) consists of a dual antiplatelet therapy with aspirin and an ADP receptor inhibitor such as clopidogrel. But measurements of platelet aggregation in clopidogrel treated patients indicate that one patient in four is a non-responder to the drug. Such non-responsiveness is attributed to clopidogrel's...

Connie K. Ho for redOrbit.com – Your Universe Online The Food and Drug Administration (FDA) recently approved the sale and distribution of Stribild, an HIV medication that includes four different drugs in one pill. The FDA believes that Stribild offers complete treatment for infections related to HIV. The cost of the drug is about $28,500 for a year’s supply, which gives manufacturer Gilead Sciences Inc. unlimited pricing power as the company retains ownership of all the ingredients...

Prasugrel versus clopidogrel for ACS patients managed without revascularization The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularization has found no significant difference between prasugrel and clopidogrel in the prevention of death, myocardial infarction or stroke. The findings, from the phase III Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary...

Potential long-term benefit observed for first time in ACS patients The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists. The study also showed no difference in serious bleeding complications. At...

INDIANAPOLIS and TOKYO, Aug. 26, 2012 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) today announced data from the TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in patients with unstable angina (UA) or non-ST elevation myocardial infarction (NSTEMI), who were managed medically without an artery-opening procedure. At 30 months, 13.9 percent of prasugrel patients vs. 16.0 percent of...

BOULDER, Colo., Aug. 23, 2012 /PRNewswire/ -- Biodesix today announced that VeriStrat results from two phase II advanced lung cancer trials will be presented at the upcoming 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. The first study will be presented by Karen Reckamp, MD (City of Hope Comprehensive Cancer Center) and reports on the analysis of pre-treatment serum samples from a Phase II study evaluating erlotinib or erlotinib plus high-dose celecoxib in advanced...

200-year long dispute over smelly mineral from Upper Palatinate resolved Fluorine is the most reactive of all chemical elements and calls for extremely careful handling. It is so aggressive that glass laboratory instruments cannot resist it and even bricks burn when exposed to fluorine gas. Yet elemental fluorine has numerous industrial applications including corrosion prevention or fuel tank diffusion barriers and it is used for the production of sulphur hexafluoride, which serves as...